Strategies for Assessing and Addressing Confounding
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 20, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Chiara Brombin1, Clelia Di Serio2
1University Centre for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele University, Italy.
This study introduces a new statistical method to compare treatments for relapsing-remitting multiple sclerosis (MS). The approach helps determine the superiority of therapies like interferons or glatiramer acetate for managing MS symptoms.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: